| 查看: 129 | 回复: 0 | |||
| 当前主题已经存档。 | |||
[交流]
The naming of Extend-Release Preparations in EU
|
|||
|
Regarding the extended-release preparations, here are definitions of the terms. On the y-axis(vertical) is the amount of active substance absorbed. On the x-axis(horizontal) is time. a: Normal tablet. Immediate action. b: Delayed-release. As you can see the beginning of the absorption is delayed (sometimes by coating the tablet with a gastric resistant layer). This may be because the tablet is supposed to be absorbed from the small intestine and the additional time is needed do it may pass through the stomach(so substances are sensitive to low pH and may be inactivated by gastric acids). c, d, e: Repeat-action preparation. The active substance is placed in layers within a tablet so that it is released in bursts a couple of times depending on the amounts of layers. f: Prolonged release or sustained release. I believe that those two terms are the same. The substance is released more slowly for a longer period of time. As you may notice amount of active substance released decreases with time.(this is a most common type and I believe that is the same as the Chinese sustained-release) g: Those are mixed tablets rarely used and I am not sure how are they called. h: Controlled-release. It is also called therapeutic systems. It is most modern and innovative tablet(laser boring tablet). As you may notice the amount of active substance released is constant in time) Apart from those terms there is still modified-release that I think is the term for all of those except above except a(Normal tablet). Any tablet where the release of the active substance has been changed or modified in any way. Also the term extended release is not very accurate as it can be related to many of the above terms. |
回复此楼» 猜你喜欢
二乙烯基砜的合成路径
已经有4人回复
-
求助电子版：晶型药物研发理论与应用
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有191人回复
-
祈福面上能中
已经有141人回复
-
求一株[b]敲除MTAP(human)的HCT-116(人结肠癌细胞)/b]细胞
已经有0人回复
-
求助！求美国食品化学药典内容：FCC13【低聚果糖专论】
已经有0人回复
-
【2027博士申请】纳米药物递送方向
已经有4人回复
-
消耗微量API，便可预测早期研发阶段的HME工艺可行性
已经有0人回复
-
反应液中苯酐除去
已经有1人回复
-
北京大学药学院诚招药物化学/有机化学方向博士后
已经有5人回复
20